Nanomaterial and beneficial fungi combination for induced immunity in musa acuminata against fusarium oxysporum

Overview

This research proposes a novel plant-triggered immunity approach for Musa acuminata (banana) using advanced nanomaterials in combination with beneficial fungal strains. The technology addresses the urgent agricultural challenge of Fusarium oxysporum, the causal agent of Panama disease, one of the most destructive threats to global banana production. By leveraging the physical properties of doped zinc oxide nanoparticles to induce reactive oxygen species (ROS) signaling, the approach modulates plant resistance to both biotic and abiotic stress conditions through the activation of secondary metabolism. The coupling of ex vitro beneficial fungi interactions further strengthens the plant's natural defense mechanisms.

The value proposition lies in offering a sustainable, non-chemical alternative to conventional fungicides, which face increasing regulatory restrictions and resistance development. This dual-component strategy, nanomaterials plus beneficial microbes, represents an integrated biocontrol solution for high-value banana cultivation and potentially other crops susceptible to Fusarium.

Technical specifications

Nanomaterial composition:

• Eight doped zinc oxide nanoparticle variants: Zn1-xCexO and Zn1-xLaxO at cerium and lanthanum concentrations of 0, 1, 5, and 10 atomic percent
• Doping enables continuous transitions of oxidation states at the cell and tissue level, driving constant ROS production for sustained acquired resistance

Mechanism of action:

• Nanomaterials trigger ROS signaling pathways that induce secondary metabolites related to plant stress resistance
• In vitro application with controlled exposure times initiates the first stimuli in the immune response
• Ex vitro interaction with beneficial fungi amplifies resistance to Fusarium oxysporum in M. acuminata

Validated properties:

• ROS production confirmed using guaiacol as substrate in nanocatalysis assays (n=6 per material)
• Antibacterial activity correlated with physical properties in quantitative experiments (n=4 per control and treatment)
• Significant differences in reducing sugars induction demonstrated in in vitro Agave potatorum cultures at 40 mg/L with two exposure times (n=8)

Technology readiness level

The technology is currently at an early-to-mid stage of development. Preliminary validation has been completed for nanomaterial synthesis, ROS generation capacity, and biological activity in a related plant model (Agave potatorum). The next phase of validation will establish in vitro cultures of M. acuminata, isolate the pathogenic Fusarium oxysporum strain, and systematically test nanoparticle concentrations and exposure times. Following ex vitro acclimation and bio-stimulation with beneficial fungi, plants will be challenged with Fusarium to measure disease incidence and resistance. The projected timeline for completing these validation studies is approximately one and a half years. The technology is positioned for collaborative research partnerships to advance toward field application.